Change of Auditor
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, announces that it has appointed Gravita II LLP as the Company's auditor.
In accordance with section 519 of the Companies Act 2006, the previous auditor, Saffery LLP, has deposited with the Company a statement confirming that there are no matters to be brought to the attention of the Company's members or creditors.
| SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Caroline Rowe (Corporate Finance) Vadim Alexandre/Abigail Wayne/Rob Rees (Corporate Broking) | Tel: +44(0)20 3470 0470 |
| Turner Pope Investments (TPI) Limited Joint Broker Andy Thacker James Pope | Tel: +44(0)20 3657 0050 |
About N4 Pharma
For further information on the Company visit www.n4pharma.com or sign up at investors.n4pharma.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.